Lates News

date
17/09/2025
On September 16th, local time, Regeneron announced plans to build a $5 billion production facility in Goochland County, west of Richmond, Virginia. This new site will be the company's first fully integrated active pharmaceutical ingredient (API) and drug manufacturing facility dedicated to serving its emerging biologics and monoclonal antibody product lines. The production facility is expected to be completed within the next five years. (Jiemian)